Tag Archives: NSCLC

Combination of Pembrolizumab Plus cCRT Demonstrated Promising Outcomes in Patients with Unresectable, Locally Advanced NSCLC

According to follow up data presented at the International Association for the Study of Lung Cancer 2020 World Conference on […]

July 15, 2021

FDA Granted Approval Of First Companion Diagnostic Test for Expanded EGFR TKIs in NSCLC

According to a press release, Roche (the test developer) announced that, “The Food and Drug Administration has approved the cobas […]

April 16, 2021